"Different science choices could have huge downstream impacts on timing, capital, customers, or how big the business might be." - Phil Morle
Main Sequence Ventures Partner Phil Morle shares insights from chairing breakthrough deep tech companies like Samsara Eco and V2 Foods about the governance challenges facing science-based businesses.
Phil explains how boards can bridge the gap between laboratory innovation and commercial success, focusing on practical approaches to oversight when directors may not fully understand the underlying technology.
He discusses the importance of curiosity over expertise, creating forums for productive dialogue between scientific and commercial teams, and establishing metrics that connect scientific progress to business outcomes.
Drawing from real examples including Eden Brew's dairy protein development and engineering decisions at scale-up stage, Phil provides a roadmap for effective deep tech governance.
_____________
Follow Podcast Host Richard Conway on LinkedIn
Follow boardcycle on LinkedIn
Visit the boardcycle website